Association between antibiotic prescriptions for acute upper respiratory infections and pneumonia among older adults: a nationwide cohort study
Abstract
Antibiotics are frequently prescribed for acute upper respiratory infections (URIs) despite limited evidence of their effectiveness, particularly in older individuals. Understanding the potential associations of such prescriptions with subsequent health outcomes is critical for clinical decision-making. This study investigated the association between antibiotic prescription and pneumonia diagnosis among older adults with acute URIs in the Republic of Korea. We conducted a retrospective analysis using national health insurance claims data from January 1, 2018, to December 31, 2018. The study included 5,898,239 prescription units from 3,059,864 patients aged ≥ 65 years diagnosed with acute URIs. Antibiotic prescription status, pneumonia diagnoses, and patient characteristics such as age, sex, and comorbidities were analyzed. Multivariate logistic regression was used to evaluate associations with pneumonia diagnoses. Of all prescription units analyzed, 34.4% included antibiotics. Pneumonia was diagnosed in 7.1% of all units, with a higher proportion in the antibiotic group (8.1%) than in the non-antibiotic group (6.6%). After adjusting for age, sex, and comorbidities, antibiotic prescription was associated with a 1.3-fold higher likelihood of pneumonia diagnosis. Higher odds of pneumonia were also observed in men, older individuals, and those with chronic conditions such as chronic obstructive pulmonary disease, heart failure, cancer, ischemic heart disease, and diabetes. Among…
How strong is the evidence?
Evidence Hub reads this as a cohort study, done in people. Its evidence level is 3 of 5 (Moderate · trial / cohort / secondary analysis). Trials without a large randomized design, cohorts and secondary analyses give moderate evidence. Reported size: 3,059,864 participants or records.
Read the paper
Related studies
- Severe clinical outcomes of COVID-19 associated with proton pump inhibitors: a nationwide cohort study with propensity score matching
- Penicillins for Treatment of Pneumococcal Pneumonia: Does In Vitro Resistance Really Matter?
- Thiophenes—Naturally Occurring Plant Metabolites: Biological Activities and In Silico Evaluation of Their Potential as Cathepsin D Inhibitors
- Inhalable Mannosylated Rifampicin–Curcumin Co-Loaded Nanomicelles with Enhanced In Vitro Antimicrobial Efficacy for an Optimized Pulmonary Tuberculosis Therapy
- Development and validation of microbial bioassay for quantification of Levofloxacin in pharmaceutical preparations
- Association between cord blood 25-hydroxyvitamin D concentrations and respiratory tract infections in the first 6 months of age in a Korean population: a birth cohort study (COCOA)
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.